McGarry ME - Search Results

1

Detection of disease-causing CFTR variants in state newborn screening programs.

McGarry ME, Ren CL, Wu R, Farrell PM, McColley SA. McGarry ME, et al. Pediatr Pulmonol. 2023 Feb;58(2):465-474. doi: 10.1002/ppul.26209. Epub 2022 Oct 25. Pediatr Pulmonol. 2023. PMID: 36237137 Free PMC article.

2

Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis.

McGarry ME, McColley SA. McGarry ME, et al. Ann Am Thorac Soc. 2016 Oct;13(10):1721-1725. doi: 10.1513/AnnalsATS.201603-192BC. Ann Am Thorac Soc. 2016. PMID: 27410177 Free PMC article.

3

In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.

McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW. McGarry ME, et al. Pediatr Pulmonol. 2017 Apr;52(4):472-479. doi: 10.1002/ppul.23659. Epub 2017 Jan 9. Pediatr Pulmonol. 2017. PMID: 28068001 Free PMC article. Clinical Trial.

4

Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP. McGarry ME, et al. Pediatr Pulmonol. 2017 Dec;52(12):1550-1557. doi: 10.1002/ppul.23884. Epub 2017 Oct 30. Pediatr Pulmonol. 2017. PMID: 29082671 Free PMC article.

5

Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

McGarry ME, Neuhaus JM, Nielson DW, Ly NP. McGarry ME, et al. Pediatr Pulmonol. 2019 Sep;54(9):1382-1390. doi: 10.1002/ppul.24377. Epub 2019 May 29. Pediatr Pulmonol. 2019. PMID: 31144477 Free PMC article.

6

Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico.

Zeiger AM, McGarry ME, Mak ACY, Medina V, Salazar S, Eng C, Liu AK, Oh SS, Nuckton TJ, Jain D, Blackwell TW, Kang HM, Abecasis G, Oñate LC, Seibold MA, Burchard EG, Rodriguez-Santana J. Zeiger AM, et al. Among authors: mcgarry me. Pediatr Pulmonol. 2020 Feb;55(2):533-540. doi: 10.1002/ppul.24549. Epub 2019 Oct 30. Pediatr Pulmonol. 2020. PMID: 31665830 Free PMC article.

7

The demographics of adverse outcomes in cystic fibrosis.

McGarry ME, Williams WA 2nd, McColley SA. McGarry ME, et al. Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S74-S83. doi: 10.1002/ppul.24434. Pediatr Pulmonol. 2019. PMID: 31715087 Free PMC article. Review.

8

Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.

McGarry ME, McColley SA. McGarry ME, et al. Pediatr Pulmonol. 2021 Jun;56(6):1496-1503. doi: 10.1002/ppul.25285. Epub 2021 Feb 1. Pediatr Pulmonol. 2021. PMID: 33470563 Free PMC article.

9

Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households.

Lim JT, Ly NP, Willen SM, Iwanaga K, Gibb ER, Chan M, Church GD, Neemuchwala F, McGarry ME. Lim JT, et al. Among authors: mcgarry me. Pediatr Pulmonol. 2022 May;57(5):1238-1244. doi: 10.1002/ppul.25850. Epub 2022 Feb 14. Pediatr Pulmonol. 2022. PMID: 35112507

10

In response to "who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies".

McGarry ME, McColley SA, Taylor-Cousar J. McGarry ME, et al. Respir Med. 2022 Oct;202:106953. doi: 10.1016/j.rmed.2022.106953. Epub 2022 Aug 22. Respir Med. 2022. PMID: 36049345 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page